{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:47:50Z","timestamp":1790750870404,"version":"4.1.0"},"reference-count":101,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,11]],"date-time":"2020-10-11T00:00:00Z","timestamp":1602374400000},"content-version":"am","delay-in-days":406,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.lpm.2019.07.031","type":"journal-article","created":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T17:06:12Z","timestamp":1568912772000},"page":"919-930","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Physiopathologie de l\u2019art\u00e9rite \u00e0 cellules g\u00e9antes\u00a0: de l\u2019inflammation au remodelage vasculaire"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8136-2454","authenticated-orcid":false,"given":"Alexis","family":"R\u00e9gent","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim Heang","family":"Ly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Mouthon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lpm.2019.07.031_bib0510","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/S0755-4982(04)98939-7","article-title":"Is giant cell arteritis an infectious disease? Biological and epidemiological evidence","volume":"33","author":"Duhaut","year":"2004","journal-title":"Presse Med"},{"key":"10.1016\/j.lpm.2019.07.031_bib0515","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1097\/PAS.0000000000000244","article-title":"Inflamed temporal artery: histologic findings in 354 biopsies, with clinical correlations","volume":"38","author":"Cavazza","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.lpm.2019.07.031_bib0520","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1172\/JCI119477","article-title":"Glucocorticoid-mediated repression of cytokine gene transcription in human arteritis-SCID chimeras","volume":"99","author":"Brack","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.lpm.2019.07.031_bib0525","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1038\/nm1297-1346","article-title":"Murine gamma-herpesvirus 68 causes severe large-vessel arteritis in mice lacking interferon-gamma responsiveness: a new model for virus-induced vascular disease","volume":"3","author":"Weck","year":"1997","journal-title":"Nat Med"},{"key":"10.1016\/j.lpm.2019.07.031_bib0530","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1161\/CIRCULATIONAHA.104.519132","article-title":"Elastic-vessel arteritis in interleukin-1 receptor antagonist-deficient mice involves effector Th1 cells and requires interleukin-1 receptor","volume":"111","author":"Shepherd","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.lpm.2019.07.031_bib0535","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.immuni.2008.10.011","article-title":"IRF-4-binding protein inhibits interleukin-17 and interleukin-21 production by controlling the activity of IRF-4 transcription factor","volume":"29","author":"Chen","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.lpm.2019.07.031_bib0540","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1007\/s10067-007-0610-5","article-title":"Horton's three sisters: familial clustering of temporal arteritis","volume":"26","author":"Raptis","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.lpm.2019.07.031_bib0545","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1136\/ard.59.7.574a","article-title":"HLA-DRB1*04 may be a marker of severity in giant cell arteritis","volume":"59","author":"Gonzalez-Gay","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2019.07.031_bib0550","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1136\/ard.57.6.380","article-title":"Relation between HLA-DRB1 alleles and corticosteroid resistance in giant cell arteritis","volume":"57","author":"Rauzy","year":"1998","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2019.07.031_bib0555","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1093\/rheumatology\/kel324","article-title":"Contribution of MHC class I region to genetic susceptibility for giant cell arteritis","volume":"46","author":"Gonzalez-Gay","year":"2007","journal-title":"Rheumatol Oxf Engl"},{"key":"10.1016\/j.lpm.2019.07.031_bib0560","first-page":"2413","article-title":"Epistatic interactions between HLA-DRB1 and interleukin 4, but not interferon-gamma, increase susceptibility to giant cell arteritis","volume":"31","author":"Amoli","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2019.07.031_bib0565","first-page":"507","article-title":"MCP-1 gene haplotype association in biopsy-proven giant cell arteritis","volume":"32","author":"Amoli","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2019.07.031_bib0570","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1093\/rheumatology\/ker429","article-title":"Association of NOS2 and potential effect of VEGF, IL6, CCL2 and IL1RN polymorphisms and haplotypes on susceptibility to GCA\u00a0\u2013\u00a0a simultaneous study of 130 potentially functional SNPs in 14 candidate genes","volume":"51","author":"Enjuanes","year":"2012","journal-title":"Rheumatol Oxf Engl"},{"key":"10.1016\/j.lpm.2019.07.031_bib0575","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s11033-012-2175-x","article-title":"Toll-like receptor polymorphisms and vasculitis susceptibility: meta-analysis and systematic review","volume":"40","author":"Song","year":"2013","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.lpm.2019.07.031_bib0580","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1002\/art.23457","article-title":"Association of a nonsynonymous single nucleotide polymorphism of matrix metalloproteinase 9 with giant cell arteritis","volume":"58","author":"Rodr\u00edguez-Pla","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2019.07.031_bib0585","first-page":"S18","article-title":"Interferon-gamma gene microsatellite polymorphisms in patients with biopsy-proven giant cell arteritis and isolated polymyalgia rheumatica","volume":"22","author":"Gonzalez-Gay","year":"2004","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.lpm.2019.07.031_bib0590","first-page":"S12","article-title":"Role of the rs6822844 gene polymorphism at the IL2-IL21 region in biopsy-proven giant cell arteritis","volume":"29","author":"Rodr\u00edguez-Rodr\u00edguez","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.lpm.2019.07.031_bib0595","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ajhg.2016.11.013","article-title":"A genome wide association study identifies risk alleles in plasminogen and P4HA2 associated with giant cell arteritis","volume":"100","author":"Carmona","year":"2017","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.lpm.2019.07.031_bib0600","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1136\/annrheumdis-2014-207116","article-title":"DNA methylation analysis of the temporal artery microenvironment in giant cell arteritis","volume":"75","author":"Coit","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2019.07.031_bib0605","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1136\/annrheumdis-2015-207846","article-title":"MicroRNA markers of inflammation and remodelling in temporal arteries from patients with giant cell arteritis","volume":"75","author":"Croci","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2019.07.031_bib0610","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1084\/jem.179.3.951","article-title":"Distinct vascular lesions in giant cell arteritis share identical T cell clonotypes","volume":"179","author":"Weyand","year":"1994","journal-title":"J Exp Med"},{"key":"10.1016\/j.lpm.2019.07.031_bib0615","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1006\/clin.1996.0078","article-title":"Clonally expanded CD8 T cells in patients with polymyalgia rheumatica and giant cell arteritis","volume":"79","author":"Martinez-Taboada","year":"1996","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.lpm.2019.07.031_bib0620","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1002\/1529-0131(199906)42:6<1255::AID-ANR23>3.0.CO;2-P","article-title":"The role of parvovirus B19 in the pathogenesis of giant cell arteritis: a preliminary evaluation","volume":"42","author":"Gabriel","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2019.07.031_bib0625","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1136\/ard.2004.025320","article-title":"Human parvovirus B19, varicella zoster virus, and human herpes virus 6 in temporal artery biopsy specimens of patients with giant cell arteritis: analysis with quantitative real time polymerase chain reaction","volume":"64","author":"Alvarez-Lafuente","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2019.07.031_bib0630","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1309\/2996TT2CTLTKN0KT","article-title":"High prevalence of herpes simplex virus DNA in temporal arteritis biopsy specimens","volume":"123","author":"Powers","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.lpm.2019.07.031_bib0635","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/rheumatology\/41.4.445","article-title":"No evidence of parvovirus B19, Chlamydia pneumoniae or human herpes virus infection in temporal artery biopsies in patients with giant cell arteritis","volume":"41","author":"Helweg-Larsen","year":"2002","journal-title":"Rheumatol Oxf Engl"},{"key":"10.1016\/j.lpm.2019.07.031_bib0640","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.carpath.2006.05.007","article-title":"Failure to detect human herpes simplex virus, cytomegalovirus, and Epstein-Barr virus viral genomes in giant cell arteritis biopsy specimens by real time quantitative polymerase chain reaction","volume":"15","author":"Cankovic","year":"2006","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.lpm.2019.07.031_bib0645","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1001\/jamaneurol.2015.2101","article-title":"Analysis of Varicella Zoster virus in temporal arteries biopsy positive and negative for giant cell arteritis","volume":"72","author":"Nagel","year":"2015","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.lpm.2019.07.031_bib0650","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/jmv.21092","article-title":"Infection and temporal arteritis: a PCR-based study to detect pathogens in temporal artery biopsy specimens","volume":"80","author":"Cooper","year":"2008","journal-title":"J Med Virol"},{"key":"10.1016\/j.lpm.2019.07.031_bib0655","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/ana.410440323","article-title":"Search for varicella zoster virus in giant cell arteritis","volume":"44","author":"Nordborg","year":"1998","journal-title":"Ann Neurol"},{"key":"10.1016\/j.lpm.2019.07.031_bib0660","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1002\/1529-0131(200007)43:7<1543::AID-ANR19>3.0.CO;2-8","article-title":"Detection of Chlamydia pneumoniae in giant cell vasculitis and correlation with the topographic arrangement of tissue-infiltrating dendritic cells","volume":"43","author":"Wagner","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2019.07.031_bib0665","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1128\/JCM.02438-08","article-title":"No correlation between giant cell arteritis and Chlamydia pneumoniae infection: investigation of 189 patients by standard and improved PCR methods","volume":"47","author":"Njau","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.lpm.2019.07.031_bib0670","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1080\/030097400750001941","article-title":"Chlamydia pneumoniae not detected in temporal artery biopsies from patients with temporal arteritis","volume":"29","author":"Haugeberg","year":"2000","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.lpm.2019.07.031_bib0675","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1136\/annrheumdis-2016-210152","article-title":"Infections and the risk of incident giant cell arteritis: a population-based, case-control study","volume":"76","author":"Rhee","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2019.07.031_bib0680","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/S0002-9440(10)64458-6","article-title":"Trapping of misdirected dendritic cells in the granulomatous lesions of giant cell arteritis","volume":"161","author":"Krupa","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.lpm.2019.07.031_bib0685","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1084\/jem.20030850","article-title":"Activation of arterial wall dendritic cells and breakdown of self-tolerance in giant cell arteritis","volume":"199","author":"Ma-Krupa","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.lpm.2019.07.031_bib0690","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1161\/CIRCULATIONAHA.108.789172","article-title":"Vessel-specific Toll-like receptor profiles in human medium and large arteries","volume":"118","author":"Pryshchep","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.lpm.2019.07.031_bib0695","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1056\/NEJMcp1214825","article-title":"Giant cell arteritis and polymyalgia rheumatica","volume":"371","author":"Weyand","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2019.07.031_bib0700","first-page":"185","article-title":"Dendritic cells co-localize with activated CD4+ T cells in giant cell arteritis","volume":"21","author":"Wagner","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.lpm.2019.07.031_bib0705","first-page":"E970","article-title":"Immunoinhibitory checkpoint deficiency in medium and large vessel vasculitis","volume":"114","author":"Zhang","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.lpm.2019.07.031_bib0710","doi-asserted-by":"crossref","first-page":"ra28","DOI":"10.1126\/scisignal.aad2357","article-title":"Identification of IL-23p19 as an endothelial proinflammatory peptide that promotes gp130-STAT3 signaling","volume":"9","author":"Esp\u00edgol-Frigol\u00e9","year":"2016","journal-title":"Sci Signal"},{"key":"10.1016\/j.lpm.2019.07.031_bib0715","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1002\/art.30374","article-title":"Expression of interleukin-32 in the inflamed arteries of patients with giant cell arteritis","volume":"63","author":"Ciccia","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2019.07.031_bib0720","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1136\/annrheumdis-2012-201309","article-title":"IL-33 is overexpressed in the inflamed arteries of patients with giant cell arteritis","volume":"72","author":"Ciccia","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2019.07.031_bib0725","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1002\/art.1780370817","article-title":"CD4+ and CD8+ T cell expansions using selected TCR V and J gene segments at the onset of giant cell arteritis","volume":"37","author":"Grunewald","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2019.07.031_bib0730","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1080\/08916930903002495","article-title":"Vascular damage in giant cell arteritis","volume":"42","author":"Piggott","year":"2009","journal-title":"Autoimmunity"},{"key":"10.1016\/j.lpm.2019.07.031_bib0735","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1161\/CIRCRESAHA.108.185777","article-title":"Toll-like receptors 4 and 5 induce distinct types of vasculitis","volume":"104","author":"Deng","year":"2009","journal-title":"Circ Res"},{"key":"10.1016\/j.lpm.2019.07.031_bib0740","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1093\/rheumatology\/kev102","article-title":"Difference in the expression of IL-9 and IL-17 correlates with different histological pattern of vascular wall injury in giant cell arteritis","volume":"54","author":"Ciccia","year":"2015","journal-title":"Rheumatol Oxf Engl"},{"key":"10.1016\/j.lpm.2019.07.031_bib0745","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1136\/annrheumdis-2018-213488","article-title":"Interleukin 12 and interleukin 23 play key pathogenic roles in inflammatory and proliferative pathways in giant cell arteritis","volume":"77","author":"Conway","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2019.07.031_bib0750","doi-asserted-by":"crossref","first-page":"809","DOI":"10.3389\/fimmu.2018.00809","article-title":"Expression and function of IL12\/23 related cytokine subunits (p35, p40, and p19) in giant cell arteritis lesions: contribution of p40 to Th1- and Th17-mediated inflammatory pathways","volume":"9","author":"Esp\u00edgol-Frigol\u00e9","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.lpm.2019.07.031_bib0755","doi-asserted-by":"crossref","first-page":"3788","DOI":"10.1002\/art.34647","article-title":"Th1 and Th17 lymphocytes expressing CD161 are implicated in giant cell arteritis and polymyalgia rheumatica pathogenesis","volume":"64","author":"Samson","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2019.07.031_bib0760","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1002\/art.34327","article-title":"Interleukin-21 modulates Th1 and Th17 responses in giant cell arteritis","volume":"64","author":"Terrier","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2019.07.031_bib0765","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1136\/annrheumdis-2015-208371","article-title":"Blocking interferon \u03b3 reduces expression of chemokines CXCL9, CXCL10 and CXCL11 and decreases macrophage infiltration in ex vivo cultured arteries from patients with giant cell arteritis","volume":"75","author":"Corbera-Bellalta","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2019.07.031_bib0770","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jaut.2016.05.008","article-title":"Involvement and prognosis value of CD8(+) T cells in giant cell arteritis","volume":"72","author":"Samson","year":"2016","journal-title":"J Autoimmun"},{"key":"10.1016\/j.lpm.2019.07.031_bib0775","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1172\/JCI84181","article-title":"NADPH oxidase deficiency underlies dysfunction of aged CD8+ Tregs","volume":"126","author":"Wen","year":"2016","journal-title":"J Clin Invest"},{"key":"10.1016\/j.lpm.2019.07.031_bib0780","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1161\/CIRCULATIONAHA.110.936203","article-title":"Blocking the NOTCH pathway inhibits vascular inflammation in large-vessel vasculitis","volume":"123","author":"Piggott","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.lpm.2019.07.031_bib0785","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1161\/CIRCULATIONAHA.117.030423","article-title":"Inhibition of JAK-STAT signaling suppresses pathogenic immune responses in medium and large vessel vasculitis","volume":"137","author":"Zhang","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.lpm.2019.07.031_bib0790","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1136\/annrheumdis-2017-211860","article-title":"Artery tertiary lymphoid organs in giant cell arteritis are not exclusively located in the media of temporal arteries","volume":"77","author":"Graver","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2019.07.031_bib0795","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1136\/ard.2007.084947","article-title":"Pathological features of temporal arteries in patients with giant cell arteritis presenting with permanent visual loss","volume":"68","author":"Chatelain","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2019.07.031_bib0800","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1002\/art.38625","article-title":"Disturbed B cell homeostasis in newly diagnosed giant cell arteritis and polymyalgia rheumatica","volume":"66","author":"van der Geest","year":"2014","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"key":"10.1016\/j.lpm.2019.07.031_bib0805","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1177\/096120339700600608","article-title":"Anti-endothelial cell antibodies in systemic autoimmune diseases: prevalence and clinical significance","volume":"6","author":"Navarro","year":"1997","journal-title":"Lupus"},{"key":"10.1016\/j.lpm.2019.07.031_bib0810","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1191\/0961203302lu168xx","article-title":"Anti-endothelial cell antibodies and biopsy-proven temporal arteritis","volume":"11","author":"Amor-Dorado","year":"2002","journal-title":"Lupus"},{"key":"10.1016\/j.lpm.2019.07.031_bib0815","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1093\/rheumatology\/key017","article-title":"mTOR pathway is activated in endothelial cells from patients with Takayasu arteritis and is modulated by serum immunoglobulin G","volume":"57","author":"Hadjadj","year":"2018","journal-title":"Rheumatol Oxf Engl"},{"key":"10.1016\/j.lpm.2019.07.031_bib0820","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1093\/rheumatology\/37.10.1129","article-title":"Absence of anti-beta2 glycoprotein I antibodies in giant cell arteritis: a study of 45 biopsy-proven cases","volume":"37","author":"Liozon","year":"1998","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.lpm.2019.07.031_bib0825","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1002\/1529-0131(199804)41:4<701::AID-ART18>3.0.CO;2-P","article-title":"Anticardiolipin antibodies and giant cell arteritis: a prospective, multicenter case-control study. Groupe de Recherche sur l\u2019Art\u00e9rite \u00e0 Cellules G\u00e9antes","volume":"41","author":"Duhaut","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2019.07.031_bib0830","first-page":"359","article-title":"Late thrombotic events in patients with temporal arteritis and anticardiolipin antibodies","volume":"8","author":"Cid","year":"1990","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.lpm.2019.07.031_bib0835","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1056\/NEJMoa1312890","article-title":"Inhibition of the mTORC pathway in the antiphospholipid syndrome","volume":"371","author":"Canaud","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2019.07.031_bib0840","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1046\/j.1365-2249.2002.01751.x","article-title":"Analysis of the B cell repertoire against autoantigens in patients with giant cell arteritis and polymyalgia rheumatica","volume":"127","author":"Schmits","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.lpm.2019.07.031_bib0845","first-page":"1107","article-title":"Serum levels of antibodies to Chlamydia pneumoniae and human HSP60 in giant cell arteritis patients","volume":"26","author":"L\u00f3pez-Hoyos","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.lpm.2019.07.031_bib0850","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1136\/annrheumdis-2011-200413","article-title":"Association of ferritin autoantibodies with giant cell arteritis\/polymyalgia rheumatica","volume":"71","author":"Baerlecken","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2019.07.031_bib0855","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1136\/annrheumdis-2012-202963","article-title":"Contribution of antiferritin antibodies to diagnosis of giant cell arteritis","volume":"72","author":"R\u00e9gent","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2019.07.031_bib0860","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jaut.2012.10.003","article-title":"Progranulin antibodies in autoimmune diseases","volume":"42","author":"Thurner","year":"2013","journal-title":"J Autoimmun"},{"key":"10.1016\/j.lpm.2019.07.031_bib0865","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.immuni.2015.05.015","article-title":"Artery tertiary lymphoid organs control aorta immunity and protect against atherosclerosis via vascular smooth muscle cell lymphotoxin \u03b2 receptors","volume":"42","author":"Hu","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.lpm.2019.07.031_bib0870","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1136\/annrheumdis-2016-209217","article-title":"Ectopic expression of CXCL13, BAFF, APRIL and LT-\u03b2 is associated with artery tertiary lymphoid organs in giant cell arteritis","volume":"76","author":"Ciccia","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2019.07.031_bib0875","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3389\/fimmu.2019.00083","article-title":"Massive B cell infiltration and organization into artery tertiary lymphoid organs in the aorta of large vessel giant cell arteritis","volume":"10","author":"Graver","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.lpm.2019.07.031_bib0880","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1093\/rheumatology\/kel128","article-title":"Association between increased CCL2 (MCP-1) expression in lesions and persistence of disease activity in giant cell arteritis","volume":"45","author":"Cid","year":"2006","journal-title":"Rheumatol Oxf Engl"},{"key":"10.1016\/j.lpm.2019.07.031_bib0885","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1172\/JCI117428","article-title":"Functional profile of tissue-infiltrating and circulating CD68+ cells in giant cell arteritis. Evidence for two components of the disease","volume":"94","author":"Wagner","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.lpm.2019.07.031_bib0890","unstructured":"Watanabe R, Hilhorst M, Zhang H, Zeisbrich M, Berry GJ, Wallis BB, et al. Glucose metabolism controls disease-specific signatures of macrophage effector functions. Clin Med n.d.:15."},{"key":"10.1016\/j.lpm.2019.07.031_bib0895","doi-asserted-by":"crossref","first-page":"6553","DOI":"10.1038\/s41598-017-06826-4","article-title":"Involvement of monocyte subsets in the immunopathology of giant cell arteritis","volume":"7","author":"van Sleen","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.lpm.2019.07.031_bib0900","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1172\/JCI4711","article-title":"Aldose reductase functions as a detoxification system for lipid peroxidation products in vasculitis","volume":"103","author":"Rittner","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.lpm.2019.07.031_bib0905","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/1529-0131(199804)41:4<623::AID-ART9>3.0.CO;2-6","article-title":"Platelet-derived growth factor, intimal hyperplasia, and ischemic complications in giant cell arteritis","volume":"41","author":"Kaiser","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2019.07.031_bib0910","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0002-9440(10)65175-9","article-title":"Formation of new vasa vasorum in vasculitis. Production of angiogenic cytokines by multinucleated giant cells","volume":"155","author":"Kaiser","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1016\/j.lpm.2019.07.031_bib0915","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0002-9440(10)64163-6","article-title":"Reactive nitrogen intermediates in giant cell arteritis: selective nitration of neocapillaries","volume":"161","author":"Borkowski","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.lpm.2019.07.031_bib0920","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1136\/ard.2006.068148","article-title":"Gelatinase expression and proteolytic activity in giant cell arteritis","volume":"66","author":"Segarra","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.lpm.2019.07.031_bib0925","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1161\/CIRCRESAHA.118.313206","article-title":"Matrix metalloprotease-9 (MMP-9)-producing monocytes enable T cells to invade the vessel wall and cause vasculitis","volume":"123","author":"Watanabe","year":"2018","journal-title":"Circ Res"},{"key":"10.1016\/j.lpm.2019.07.031_bib0930","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1161\/CIRCULATIONAHA.104.520114","article-title":"Metalloproteinase-2 and -9 in giant cell arteritis: involvement in vascular remodeling","volume":"112","author":"Rodr\u00edguez-Pla","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.lpm.2019.07.031_bib0935","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1186\/s13075-014-0487-z","article-title":"Neurotrophins are expressed in giant cell arteritis lesions and may contribute to vascular remodeling","volume":"16","author":"Ly","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.lpm.2019.07.031_bib0940","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1136\/ard.2008.105692","article-title":"Increased expression of the endothelin system in arterial lesions from patients with giant cell arteritis: association between elevated plasma endothelin levels and the development of ischaemic events","volume":"69","author":"Lozano","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2019.07.031_bib0945","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1136\/annrheumdis-2016-210792","article-title":"Endothelin-1 promotes vascular smooth muscle cell migration across the artery wall: a mechanism contributing to vascular remodelling and intimal hyperplasia in giant cell arteritis","volume":"76","author":"Planas-Rigol","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2019.07.031_bib0950","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.autrev.2017.02.006","article-title":"Molecular analysis of vascular smooth muscle cells from patients with giant cell arteritis: targeting endothelin-1 receptor to control proliferation","volume":"16","author":"R\u00e9gent","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.lpm.2019.07.031_bib0955","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/1529-0131(200001)43:1<184::AID-ANR23>3.0.CO;2-N","article-title":"Cell adhesion molecules in the development of inflammatory infiltrates in giant cell arteritis: inflammation-induced angiogenesis as the preferential site of leukocyte-endothelial cell interactions","volume":"43","author":"Cid","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2019.07.031_bib0960","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1136\/ard.58.3.189","article-title":"Circulating soluble adhesion molecules in patients with giant cell arteritis. Correlation between soluble intercellular adhesion molecule-1 (sICAM-1) concentrations and disease activity","volume":"58","author":"Coll-Vinent","year":"1999","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2019.07.031_bib0965","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1161\/01.CIR.0000030185.67510.C0","article-title":"Tissue and serum angiogenic activity is associated with low prevalence of ischemic complications in patients with giant cell arteritis","volume":"106","author":"Cid","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.lpm.2019.07.031_bib0970","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1093\/rheumatology\/kex334","article-title":"Increased expression of interleukin-22 in patients with giant cell arteritis","volume":"57","author":"Zerbini","year":"2018","journal-title":"Rheumatol Oxf Engl"},{"key":"10.1016\/j.lpm.2019.07.031_bib0975","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1002\/art.39217","article-title":"Regulation of inflammation and angiogenesis in giant cell arteritis by acute-phase serum amyloid A","volume":"67","author":"O\u2019Neill","year":"2015","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"key":"10.1016\/j.lpm.2019.07.031_bib0980","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1161\/CIRCRESAHA.114.301374","article-title":"Investigational analysis reveals a potential role for neutrophils in giant cell arteritis disease progression","volume":"114","author":"Nadkarni","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.lpm.2019.07.031_bib0985","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1136\/annrheumdis-2012-202883","article-title":"Changes in biomarkers after therapeutic intervention in temporal arteries cultured in Matrigel: a new model for preclinical studies in giant cell arteritis","volume":"73","author":"Corbera-Bellalta","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2019.07.031_bib0990","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1002\/art.1780360913","article-title":"Correlation of interleukin-6 production and disease activity in polymyalgia rheumatica and giant cell arteritis","volume":"36","author":"Roche","year":"1993","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2019.07.031_bib0995","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1002\/art.34477","article-title":"Brief report: inhibition of interleukin-6 function corrects Th17\/Treg cell imbalance in patients with rheumatoid arthritis","volume":"64","author":"Samson","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2019.07.031_bib1000","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature04753","article-title":"Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells","volume":"441","author":"Bettelli","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.lpm.2019.07.031_bib1005","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1136\/annrheumdis-2016-210070","article-title":"An expanded population of pathogenic regulatory T cells in giant cell arteritis is abrogated by IL-6 blockade therapy","volume":"76","author":"Miyabe","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2019.07.031_bib0505","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/modpathol.2017.10","article-title":"Clinical and pathological evolution of giant cell arteritis: a prospective study of follow-up temporal artery biopsies in 40 treated patients","volume":"30","author":"Maleszewski","year":"2017","journal-title":"Mod Pathol"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498219303434?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498219303434?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:05:27Z","timestamp":1760105127000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498219303434"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":101,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S0755498219303434"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2019.07.031","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Physiopathologie de l\u2019art\u00e9rite \u00e0 cellules g\u00e9antes\u00a0: de l\u2019inflammation au remodelage vasculaire","name":"articletitle","label":"Article Title"},{"value":"La Presse M\u00e9dicale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2019.07.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}